Cardiac catheterization, a key diagnostic and treatment tool for heart disease since the mid-20th century, has evolved with advances in technology, patient preparation, and recovery protocols. Modern ...
STXS stock gains after first U.S. MAGiC procedures, marking a key milestone in robotic cardiac care and boosting its growth ...
Stereotaxis (NYSE:STXS) today announced the first patients successfully treated in the U.S. with its MAGiC system.
An eight-year HonorHealth Research Institute clinical trial, using non-surgical techniques, showed 86% of patients with a type of usually fatal low blood pressure known as "structural shock" survived ...
Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the first patients in the US have been successfully treated ...
Folks undergoing cardiac catheterization procedures to diagnose heart problems may be able to safely skip the traditional pre-op fasting that's now the norm, new research shows. "Just as our ...
Long Beach, Calif. – May 2, 2024 – New data from the CALORI Cardiac Catheterization trial shows significant improvement in patient well-being and satisfaction without compromising safety after ...
Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced late-breaking ...
Many minimally invasive procedures are available to treat problems with your heart. These procedures can fix issues like malfunctioning valves and blockages in your heart’s arteries. Traditional heart ...
Please provide your email address to receive an email when new articles are posted on . Not fasting before cardiac catheterization procedures with conscious sedation was just as safe as fasting.
Add Yahoo as a preferred source to see more of our stories on Google. The Health Sciences Centre in St. John's has expanded the province's cardiac catheterization lab with a fourth procedure room, ...
Stereotaxis has completed the first U.S. procedures using its FDA‑approved MAGiC robotic magnetic ablation catheter, designed for complex congenital heart disease cases where traditional approaches ...